In a report issued on April 15, Josh Jennings from Cowen & Co. reiterated a Buy rating on Establishment Labs Holdings Inc (ESTA), with a price target of $38. The company’s shares closed yesterday at $22.30.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of 4.1% and a 55.5% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Edwards Lifesciences, and Stryker Corporation.
Establishment Labs Holdings Inc has an analyst consensus of Moderate Buy, with a price target consensus of $39.
See today’s analyst top recommended stocks >>
The company has a one-year high of $30.71 and a one-year low of $20.05. Currently, Establishment Labs Holdings Inc has an average volume of 52.69K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
